Sunshine Biopharma (SBFMW) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026)
Sunshine Biopharma (SBFMW) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | -13.67% |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 8.08% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.30% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 4.48% |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | -51.73% |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 33.24% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -5.70% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | -12.84% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 145.62% |
| 10 | Sunshine Biopharma | - | - | 2.18 Mn | -0.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.66% |
| Dec 31, 2025 | 2.07% |
| Sep 30, 2025 | 1.23% |
| Jun 30, 2025 | 17.91% |
| Mar 31, 2025 | 29.42% |
| Dec 31, 2024 | 49.25% |
| Sep 30, 2024 | 76.40% |
| Jun 30, 2024 | 47.65% |
| Mar 31, 2024 | 9.13% |
| Dec 31, 2023 | -7.20% |
| Sep 30, 2023 | 8,783.87% |
| Jun 30, 2023 | 22,231.55% |
| Mar 31, 2023 | 9,158.67% |
| Dec 31, 2022 | 5,483.47% |
| Sep 30, 2022 | -63.15% |
| Jun 30, 2022 | -87.82% |
| Mar 31, 2022 | -76.10% |
| Dec 31, 2021 | -63.85% |
| Sep 30, 2021 | -55.35% |
| Jun 30, 2021 | -48.84% |